Literature DB >> 9429857

Pituitary incidentalomas.

M E Molitch1.   

Abstract

Incidental pituitary masses are commonly found during CT and MR imaging performed for a variety of reasons. Screening for hormone oversecretion by these tumors seems to be warranted. Patients with lesions greater than 1 cm should be screened for hypopituitarism. In the absence of visual field abnormalities or hypothalamic/stalk compression, it may be appropriate to observe such patients carefully with repeated MR imaging scans. A limited amount of data suggest that significant tumor enlargement occurs in less than 5% of patients with lesions smaller than 1 cm in diameter. However, all macroadenomas must start out as microadenomas, and thus periodic follow-up is indicated to assess for this possibility. Lesions larger than 1 cm in diameter by their very existence at the time of detection have already indicated a propensity for growth. Significant tumor growth occurs in just over one-quarter of such patients. Hemorrhage into such tumors is uncommon, but anticoagulation may predispose to this complication. When there is no evidence of visual field deficits, an attempt at medical therapy with a dopamine agonist or octreotide is reasonable, realizing that only 10% of such patients will respond with a decrease in tumor size. Alternatively, careful periodic observation without intervention may determine that the lesion is not growing. Surgery is indicated with evidence of tumor enlargement, especially when such growth is accompanied by compression of the optic chiasm, cavernous sinus invasion, or the development of pituitary hormone deficiencies.

Entities:  

Mesh:

Year:  1997        PMID: 9429857     DOI: 10.1016/s0889-8529(05)70279-6

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  11 in total

Review 1.  Medical management of prolactin-secreting pituitary adenomas.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 2.  The pituitary mass: diagnosis and management.

Authors:  Susan Sam; Mark E Molitch
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

3.  Clinical and Epidemiological Characteristics of Pituitary Tumours using a Web-based Pituitary Tumour Registry in Oman.

Authors:  Abdullah Al-Futaisi; Al-Yaarubi Saif; Ibrahim Al-Zakwani; Salim Al-Qassabi; Shaden Al-Riyami; Yasser Wali
Journal:  Sultan Qaboos Univ Med J       Date:  2007-04

Review 4.  Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas.

Authors:  Mansur E Shomali; Laurence Katznelson
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 5.  Pituitary incidentalomas.

Authors:  George A Scangas; Edward R Laws
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

6.  Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients.

Authors:  Pouyan Famini; Marcel M Maya; Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2011-04-06       Impact factor: 5.958

7.  Somatotropin adenoma and resistance to thyroid hormone.

Authors:  D Berker; Y Aydin; Y A Tutuncu; S Isik; T Delibasi; M Berker; S Guler; N Kamel
Journal:  J Endocrinol Invest       Date:  2009-03       Impact factor: 4.256

8.  A 60-year-old man with progressive malaise, fatigue and decreased libido.

Authors:  M Usman Chaudhry
Journal:  CMAJ       Date:  2003-09-02       Impact factor: 8.262

9.  Pituitary incidentalomas--how often is too often?

Authors:  Mara Carsote; Corina Chirita; Anda Dumitrascu; D Hortopan; Simona Fica; Catalina Poiana
Journal:  J Med Life       Date:  2009 Jan-Mar

10.  Assessment of Environmental and Hereditary Influence on Development of Pituitary Tumors Using Dermatoglyphic Traits and Their Potential as Screening Markers.

Authors:  Marina Gradiser; Martina Matovinovic Osvatic; Dario Dilber; Ines Bilic-Curcic
Journal:  Int J Environ Res Public Health       Date:  2016-03-17       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.